Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)

OBJECTIVE: To assess the rates of vascular thrombotic adverse events in the first 35 days after one dose of the Ad26.COV2.S vaccine (Janssen/Johnson & Johnson) in healthcare workers in South Africa and to compare these rates with those observed in the general population. DESIGN: Open label, sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobson, Barry Frank, Schapkaitz, Elise, Takalani, Azwi, Rowji, Pradeep, Louw, Vernon Johan, Opie, Jessica, Bekker, Linda-Gail, Garrett, Nigel, Goga, Ameena, Reddy, Tarylee, Yende-Zuma, Nonhlanhla, Sanne, Ian, Seocharan, Ishen, Peter, Jonny, Robinson, Michelle, Collie, Shirley, Khan, Amber, Takuva, Simbarashe, Gray, Glenda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083528/
https://www.ncbi.nlm.nih.gov/pubmed/37063238
http://dx.doi.org/10.1136/bmjmed-2022-000302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083528/
https://www.ncbi.nlm.nih.gov/pubmed/37063238
http://dx.doi.org/10.1136/bmjmed-2022-000302

Ejemplares similares